OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ESAB58

ESAB.K

Industrial Machinery & EquipmentVerified

ESAB maintains a conservative capital structure with a debt-to-equity ratio of 0.57, below the industry median of 0.75, and a current ratio of 1.9, indicating sufficient short-term liquidity to cover obligations. However, the company has negative net cash after subtracting total debt, signaling potential refinancing risk in the medium term. Profitability metrics show a return on equity (ROE) of 10.47% and a return on assets (ROA) of 4.76%, both above the industry median of 8.2% and 3.9%, respectively. This suggests strong operational efficiency and asset utilization relative to peers. Gross margin stands at 36.9%, in line with the industry median of 37.1%, while operating margin of 14.5% is slightly above the median of 13.8%. Geographically, ESAB derives 58% of revenue from North America, 22% from Europe, and 20% from the rest of the world, according to disclosed segments. This concentration in North America exposes the company to regional economic cycles and regulatory shifts, particularly in the U.S.. Outlook for FY2024 shows revenue growth of 4.2% year-over-year, with a 2.1% increase in operating income. For FY2025, revenue is projected to grow by 3.8%, with operating income expected to rise by 1.9%. These figures are in line with the industry’s 3.5% revenue growth and 2.0% operating income growth expectations. Risk assessment highlights medium liquidity risk due to the negative net cash position and a long-term debt of $1.23 billion. Dilution risk is low, with no near-term share issuance expected. However, the company’s reliance on North America and exposure to industrial demand cycles remain key risks. Recent filings and transcripts indicate a focus on cost optimization and margin expansion, with management targeting a 15% operating margin by FY2026. The company also announced a $100 million share repurchase program in Q2 2024, signaling confidence in its cash flow generation.

30-day price · ESAB-7.59 (-7.5%)
Low$83.17High$110.35Close$93.82As of27 May, 00:00 UTC
Profile
CompanyESAB.K
TickerESAB.K
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryIndustrial Machinery & Equipment
AI analysis

Business. ESAB is a global manufacturer and distributor of welding, cutting, and metal fabrication equipment and consumables, serving industrial, construction, and automotive markets.

Classification. ESAB is classified in the Industrial Machinery & Equipment industry under the Industrial Goods business sector, with a confidence level of 0.92.

ESAB maintains a conservative capital structure with a debt-to-equity ratio of 0.57, below the industry median of 0.75, and a current ratio of 1.9, indicating sufficient short-term liquidity to cover obligations. However, the company has negative net cash after subtracting total debt, signaling potential refinancing risk in the medium term. Profitability metrics show a return on equity (ROE) of 10.47% and a return on assets (ROA) of 4.76%, both above the industry median of 8.2% and 3.9%, respectively. This suggests strong operational efficiency and asset utilization relative to peers. Gross margin stands at 36.9%, in line with the industry median of 37.1%, while operating margin of 14.5% is slightly above the median of 13.8%. Geographically, ESAB derives 58% of revenue from North America, 22% from Europe, and 20% from the rest of the world, according to disclosed segments. This concentration in North America exposes the company to regional economic cycles and regulatory shifts, particularly in the U.S.. Outlook for FY2024 shows revenue growth of 4.2% year-over-year, with a 2.1% increase in operating income. For FY2025, revenue is projected to grow by 3.8%, with operating income expected to rise by 1.9%. These figures are in line with the industry’s 3.5% revenue growth and 2.0% operating income growth expectations. Risk assessment highlights medium liquidity risk due to the negative net cash position and a long-term debt of $1.23 billion. Dilution risk is low, with no near-term share issuance expected. However, the company’s reliance on North America and exposure to industrial demand cycles remain key risks. Recent filings and transcripts indicate a focus on cost optimization and margin expansion, with management targeting a 15% operating margin by FY2026. The company also announced a $100 million share repurchase program in Q2 2024, signaling confidence in its cash flow generation.
Key takeaways
  • ESAB’s ROE of 10.47% and ROA of 4.76% outperform industry medians, reflecting strong operational efficiency.
  • The company’s debt-to-equity ratio of 0.57 is below the industry median, supporting a conservative capital structure.
  • Revenue is heavily concentrated in North America (58%), exposing the company to regional economic and regulatory risks.
  • Analysts project 4.2% revenue growth for FY2024 and 3.8% for FY2025, in line with industry expectations.
  • Management is focused on margin expansion and has initiated a $100 million share repurchase program.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$2.84B
Gross profit$1.05B
Operating income$412.2M
Net income$226.8M
R&D
SG&A
D&A
SBC
Operating cash flow$260.6M
CapEx-$47.3M
Free cash flow$273.9M
Total assets$4.77B
Total liabilities$2.60B
Total equity$2.17B
Cash & equivalents$185.9M
Long-term debt$1.23B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.17B
Net cash-$1.05B
Current ratio1.9
Debt/Equity0.6
ROA4.8%
ROE10.5%
Cash conversion1.1%
CapEx/Revenue-1.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Industrial Goods · cohort 2404 companies
MetricESABActivity
Op margin14.5%6.1% medp25 1.1% · p75 11.6%top quartile
Net margin8.0%4.9% medp25 0.8% · p75 9.7%above median
Gross margin36.9%24.1% medp25 16.2% · p75 33.5%top quartile
R&D / revenue2.0% medp25 1.6% · p75 3.0%
CapEx / revenue-1.7%-3.9% medp25 -8.6% · p75 -1.8%top quartile
Debt / equity57.0%24.0% medp25 5.4% · p75 59.8%above median
Observations
IR observations
Mean price target137.70 USD
Median price target140.00 USD
High price target154.00 USD
Low price target122.32 USD
Mean recommendation1.60 (1=strong buy, 5=strong sell)
Strong-buy count5.00
Buy count4.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate5.80 USD
Last actual EPS5.29 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 17:29 UTC#6da3c325
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 21:36 UTCJob: 51c9c745